Overall survival according to time-of-day of combined immuno-chemotherapy for advanced gastric cancer: a propensity score-matched analysis
Early ToDA of ICIs is associated with longer OS in patients with advanced GC receiving first-line chemotherapy combined with ICIs. Randomized clinical trials are required to validate these findings.
Authors
- Tiejun Wang (ORCID: https://orcid.org/0000-0002-2362-8007)
- Chong Cheng (ORCID: https://orcid.org/0000-0001-6630-7804)
- Xiaqin Cheng
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Hubei Cancer Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.3389/fimmu.2025.1653218
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00